Interferons in cancer therapy: a reappraisal

The use of real-world data in cancer drug development.

European journal of cancer (Oxford, England : 1990)·2018

Experimental validation of a flat punch indentation methodology calibrated against unconfined compression tests for determination of soft tissue biomechanics.

Journal of the mechanical behavior of biomedical materials·2016

Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies.

Molecular oncology·2016

Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

Growth-control of human ovarian-carcinoma cells by insulin-like growth-factors.

Oncology reports·2011

Clinically relevant fatigue in recurrence-free prostate cancer survivors.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Hypertrophic Cardiomyopathy Mimicking Cardiac Involvement on 18F-FDG PET/CT in a Patient With Lymphoma.

Clinical nuclear medicine·2026

pH-Responsive liposomes co-delivering a membrane-active peptide and the PI3Kγ inhibitor to reconstruct the tumor microenvironment for enhanced antitumor immunotherapy.

Biomaterials science·2026

Performance of a high-sensitivity troponin-based early rule-out pathway for suspected myocardial infarction.

Acta cardiologica·2026

Percutaneous Suction Drain Versus Conventional Incision and Drainage for the Management of Acute Breast Abscess: A Prospective Comparative Study.

Cureus·2026

The combination of alternating reduced-dose blinatumomab and hyper-CVAD as consolidation therapy in patients with newly-diagnosed adult B-cell acute lymphoblastic leukemia.

Therapeutic advances in hematology·2026

Immune Checkpoint Inhibitor-Related Gastrointestinal Toxicity: Pathogenesis, Diagnosis, and Management.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology·2026

Related Experiment Videos

Interferons in cancer therapy: a reappraisal

Related Concept Videos

The use of real-world data in cancer drug development.

Experimental validation of a flat punch indentation methodology calibrated against unconfined compression tests for determination of soft tissue biomechanics.

Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies.

Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy.

Growth-control of human ovarian-carcinoma cells by insulin-like growth-factors.

Clinically relevant fatigue in recurrence-free prostate cancer survivors.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Hypertrophic Cardiomyopathy Mimicking Cardiac Involvement on 18F-FDG PET/CT in a Patient With Lymphoma.

pH-Responsive liposomes co-delivering a membrane-active peptide and the PI3Kγ inhibitor to reconstruct the tumor microenvironment for enhanced antitumor immunotherapy.

Performance of a high-sensitivity troponin-based early rule-out pathway for suspected myocardial infarction.

Percutaneous Suction Drain Versus Conventional Incision and Drainage for the Management of Acute Breast Abscess: A Prospective Comparative Study.

The combination of alternating reduced-dose blinatumomab and hyper-CVAD as consolidation therapy in patients with newly-diagnosed adult B-cell acute lymphoblastic leukemia.

Immune Checkpoint Inhibitor-Related Gastrointestinal Toxicity: Pathogenesis, Diagnosis, and Management.

Related Experiment Videos

Interferons in cancer therapy: a reappraisal

Related Concept Videos

Related Articles